Document Detail

Exogenous high-mobility group box 1 protein prevents postinfarction adverse myocardial remodeling through TGF-β/Smad signaling pathway.
MedLine Citation:
PMID:  23355476     Owner:  NLM     Status:  Publisher    
High-mobility group box 1 (HMGB1) has been reported to attenuate ventricular remodeling, but its mechanism remains mostly unresolved. Transforming growth factor-beta (TGF-β) is a crucial mediator in the pathogenesis of post-infarction remodeling. Our study focused on the effects of HMGB1 on ventricular remodeling, and explored whether or not these effects were depended upon the TGF-β signaling pathway. Rats underwent coronary artery ligation. An intramyocardium injection of phosphate buffered saline (PBS) with or without HMGB1 was administered 3 weeks after myocardial infarction (MI). At 4 weeks after the treatment, HMGB1 significantly increased the Left ventricular ejection fraction (LVEF) (P<0.05), decreased the left ventricular end diastolic dimension (LVEDD) (P<0.05), left ventricular end systolic dimension (LVESD) (P<0.05) and the infarct size (P<0.05) compared with control group. The expressions of collagen I, collagen III and tissue inhibitor of metalloproteinase 2 (TIMP2) were also decreased, while the matrix metalloproteinases 2 (MMP2) and MMP9 expressions were upregulated by HMGB1 injection (P<0.05) compared with control group. No effect on TIMP3 was observed. Furthermore, TGF-β1 and phosphor-Smad2 (p-Smad2) were significantly suppressed and Smad7 was increased in HMGB1-treated group (P<0.05) compared with control group, no effects on p-Smad3 and p-p38 were observed. HMGB1 also upregulated Smad 7 expression and decreased the level of collagen I on cardiac fibroblasts (P<0.05). Silencing of Smad7 gene by small interfering RNA abolished the fibrogenic effects of HMGB1 on cardiac fibroblasts (P<0.05). These finding suggested that HMGB1 injection modulated ventricular remodeling may function through the possible inhibition of TGF-β/Smad signaling pathway. J. Cell. Biochem. © 2013 Wiley Periodicals, Inc.
Yiyu He; Xiaoya Zhou; Xiaoxin Zheng; Xuejun Jiang
Related Documents :
21444046 - Management of the ventricular septal defect during double switch operation for atrioven...
23074496 - Enhanced external counterpulsation (eecp): an evidence-based analysis.
22920486 - Thrombus extraction catheters vs. angiojet rheolytic thrombectomy in thrombotic lesions...
20615076 - Reperfusion injury salvage kinase and survivor activating factor enhancement prosurviva...
3510876 - Abdominal heart transplantation: description of a new allograft extrathoracic pump.
1735156 - Variant angina pectoris. role of coronary spasm in the development of fixed coronary ob...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-1-25
Journal Detail:
Title:  Journal of cellular biochemistry     Volume:  -     ISSN:  1097-4644     ISO Abbreviation:  J. Cell. Biochem.     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2013-1-28     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8205768     Medline TA:  J Cell Biochem     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2013 Wiley Periodicals, Inc.
Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, 430060, PR China; Cardiovascular Research Institute of Wuhan University. Wuhan, 430060, PR China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The National Cancer Institute Best Case Series Program: A Summary of Cases of Cancer Patients Treate...